Though it probably comes as no surprise, a new report confirms the DEA systematically thwarted research into both cannabis and MDMA for medicinal use and potential rescheduling. Additionally, the Drug Policy Alliance and Multidisciplinary Association for Psychedelic Studies (MAPS) found in their report, the federal government maintains an “unjustifiable monopoly” on research-grade cannabis — preventing Read More…